BioMedical

The BioMedical SIG fosters discussions on key topics in translating research into healthcare solutions, such as the bench-to-bedside process, regulatory challenges, and attracting investors. Members also explore sustainable practices in biotechnology and pharmaceuticals, including drug repurposing and natural products. This group actively generates guidelines and fosters collaborations between stakeholders.

For collaboration and professional development, contact Arlyta at HQ.